Title
Management of Cardiomyopathies
Authoring Organization
Publication Month/Year
August 25, 2023
Last Updated Month/Year
August 29, 2023
Supplemental Implementation Tools
Document Type
Guideline
Country of Publication
European
Document Objectives
The objective of this guideline is to help healthcare professionals diagnose and manage patients with cardiomyopathies of all ages according to the best available evidence and to provide a practical diagnostic and treatment framework for patients and their relatives. This is a new guideline, not an update of existing guidelines, with the exception of the section on hypertrophic cardiomyopathy (HCM), in which we have provided a focused update to the 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy. As such, most of the recommendations in this guideline are new. It is beyond the scope of this guideline to provide detailed descriptions and recommendations for each individual cardiomyopathy phenotype; instead, the aim is to provide a guide to the diagnostic approach to cardiomyopathies, highlight general evaluation and management issues, and signpost the reader to the relevant evidence base for the recommendations.
Inclusion Criteria
Male, Female, Adult, Older adult
Health Care Settings
Ambulatory, Hospital, Outpatient
Intended Users
Nurse, nurse practitioner, physician, physician assistant
Scope
Management
Diseases/Conditions (MeSH)
D009202 - Cardiomyopathies
Keywords
cardiomyopathy, cardiomyopathies
Source Citation
Elena Arbelo and others, 2023 ESC Guidelines for the management of cardiomyopathies: Developed by the task force on the management of cardiomyopathies of the European Society of Cardiology (ESC), European Heart Journal, 2023;, ehad194, https://doi.org/10.1093/eurheartj/ehad194